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Abstract 82 
While there is a rich literature on the role of dopamine in value learning, much less is known 83 
about its role in using established value estimations to shape decision-making. Here we 84 
investigated the effect of dopaminergic modulation on value-based decision-making for food 85 
items in fasted healthy human participants. The Becker-deGroot-Marschak auction, which 86 
assesses subjective value, was examined in conjunction with pharmacological functional 87 
magnetic resonance imaging (fMRI) using a dopaminergic agonist and an antagonist. We found 88 
that dopamine enhanced the neural response to value in the inferior parietal 89 
gyrus/intraparietal sulcus, and that this effect predominated towards the end of the valuation 90 
process when an action was needed to record the value. Our results suggest that dopamine is 91 
involved in acting upon the decision, providing additional insight to the mechanisms underlying 92 
impaired decision-making in healthy individuals and clinical populations with reduced 93 
dopamine levels.  94 
  95 
Dopamine modulates the neural representation of subjective value of food in hungry 
subjects  
 5 
Introduction 96 
Successful interactions with the environment – those that maximise reward and minimise 97 
punishment – entail using previous experience to predict the likely value of outcomes and the 98 
actions that obtain them.  Animal and human studies have strongly implicated the 99 
neurotransmitter dopamine in this value learning process (Bayer and Glimcher, 2005; Schultz, 100 
1998; Schultz et al., 1997; Steinberg et al., 2013; Wise, 2004; Frank and O’Reilly, 2006; Frank et 101 
al., 2004; Pessiglione et al., 2006), in addition to its other overlapping roles in shaping 102 
behaviour, including motivation (Berridge and Robinson, 1998), vigour (Niv et al., 2007) and 103 
behavioural activation (Robbins and Everitt, 2007). 104 
But choice requires not merely an ability to predict the consequences of one’s actions. One must 105 
be able to weigh up the likely values of competing possibilities. Thus, it is critical to retrieve and 106 
represent the subjective values of the options on offer in order to select the most valuable one. 107 
This value computation – an intrinsic part of decision-making - has been linked to the function 108 
of certain key brain regions in humans and non-human primates, including the ventromedial 109 
prefrontal cortex (vmPFC), ventral striatum, posterior parietal and supplementary motor cortex 110 
(Bartra et al., 2013; Clithero and Rangel, 2013; Hunt et al., 2012; O’Doherty, 2011; Platt and 111 
Glimcher, 1999; Wunderlich et al., 2009). The key question posed in the current study is 112 
whether value-related processes in these regions may be modulated by dopamine.  113 
Single cell recordings from dopamine neurons responding to reward-predicting stimuli have 114 
implicated dopamine in the neural coding of the subjective value of stimuli (Fiorillo et al., 2003; 115 
Roesch et al., 2007; Tobler et al., 2005). Furthermore, recent pharmacological studies suggested 116 
a role of dopamine in the optimal selection of most valuable stimuli within probabilistic learning 117 
tasks (Jocham et al., 2011; Shiner et al., 2012; Smittenaar et al., 2012). However, there is a 118 
critical distinction between value updating (learning) and value-based decision-making, and 119 
these cannot be fully dissociated within probabilistic learning tasks. Whereas both processes 120 
are hypothesised to be modulated by dopamine (McClure et al., 2003), the distinct role of 121 
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dopamine in decision-making, dissociated from learning, has not been experimentally 122 
investigated. To address this, we conducted a between-subject, placebo-controlled 123 
pharmacological fMRI study in healthy volunteers.  124 
We explored the effects of both a dopamine agonist and an antagonist on the subjective 125 
valuation of food items in a Becker-deGroot-Marschak (BDM) mechanism (Becker et al., 1964).  126 
The BDM replicates many aspects of second-price auctions and provides a robust means of 127 
obtaining subjective values and involves no learning component. It has been used in human 128 
neuroscience before (Grether et al., 2007; Plassmann et al., 2007).  All items in the auction were 129 
well-known everyday foods whose value subjects would have acquired through life experience, 130 
independent of our experimental manipulation. This enabled us to characterise the impact of 131 
dopaminergic modulation on the behavioural and brain processes associated primarily with 132 
decision-making. 133 
  134 
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Materials and methods 135 
Subjects 136 
Forty-seven healthy, right-handed people (23 males, aged 23.8±3.2, body mass index 21.7±1.6 137 
kg/m2 (mean±SD)) participated in the study. All subjects had normal or corrected to normal 138 
vision, had no history of psychiatric or other significant medical history, and reported no 139 
contraindications to the pharmacological agents or MRI scanning. 140 
The study was approved by the Cambridge East Local Research Ethics Committee (REC 141 
11/EE/0480) and was conducted at the Wellcome Trust Clinical Research Facility and the 142 
Wolfson Brain Imaging Centre in Addenbrooke’s Hospital, Cambridge, UK. The study was 143 
carried out in accordance with the principles of the Declaration of Helsinki. All participants 144 
provided written, informed consent.  145 
Study design 146 
In a double-blind, between-subject study, subjects received a single oral dose of either 147 
bromocriptine 1.25 mg (dopamine D2 agonist, n=15), sulpiride 400 mg (D2 antagonist, n=16) or 148 
placebo (n=16). One subject (from the sulpiride group) did not pay attention to the task and was 149 
excluded from the analysis (on over 50% of the free trials, the subject placed a bid of £0; when 150 
debriefed, she did not express any dislike of the food items on offer or a desire to keep her 151 
budget, thus calling into question her understanding of the task). Three additional subjects (one 152 
from each group) were excluded from the fMRI analysis because of severe signal dropout in the 153 
frontal lobe, as agreed on visual inspection by the study analysis team. This left 46 datasets (23 154 
males, aged 23.8±3.2, body mass index 21.7±1.6 kg/m2 (mean±SD)) for the behavioural analysis 155 
and 43 datasets (21 males, aged 23.6±2.9, body mass index 21.5±1.5 kg/m2 (mean±SD)) for the 156 
fMRI analysis. Subjects’ age (F = 0.45, p = 0.64), BMI (F = 1.02, p = 0.37) or gender (2 = 0.04, p = 157 
0.98) did not differ between the treatment groups. In addition to the task described below, 158 
participants underwent a number of other cognitive measures, which are not presented here.  159 
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Subjects attended the study session in the morning following an overnight fast. They received a 160 
standardised breakfast (based on body weight, age and gender) on the clinical research facility 161 
at 8am. This was to ensure similar baseline metabolic states across subjects and to minimise 162 
pharmacokinetic perturbations related to food and drink.   163 
Bromocriptine and sulpiride have been used in previous studies (Cools et al., 2009; Dodds et al., 164 
2009; Morcom et al., 2010), and are well tolerated at these doses.  As bromocriptine can cause 165 
nausea (Bromocriptine SPC, 2012), to maintain the double-blinding and prevent any effects of 166 
nausea on performance on a food-related task, all subjects were prophylactically given 10 mg of 167 
the anti-emetic domperidone, which does not cross the blood-brain barrier (Domperidone SPC, 168 
2012). Bromocriptine reaches peak plasma levels 1-3 hours post dose, with a half-life of about 169 
15 hours (Kvernmo et al., 2006). Sulpiride reaches its maximal plasma concentration about 3 170 
hours post dose, and has a plasma half-life of about 12 hours (Caley and Weber, 1995; Wiesel et 171 
al., 1980). The study drug and domperidone were given to all participants at 11am. The fMRI 172 
acquisition started approximately 2.5 hours after receiving the drugs (at ~1:30 pm) to capture 173 
the window of maximal drug effect. 174 
fMRI task 175 
A computerised version of the BDM auction was developed, in which participants could bid for 176 
50 different foods, represented by photographs (see Figure 1A). Participants were given a fixed 177 
budget, and the auction procedure incentives participants to place bids as close as possible to 178 
their real subjective value.  179 
In addition to their study participation fee, before entering the scanner, participants were 180 
handed a budget of £3 for bidding. This was physically given to them to ensure they regarded 181 
the budget as their own money. They were instructed that on each trial they could place a bid 182 
between £0 and £3 for the presented item. Responses were made on a sliding scale that went 183 
from £0 to £3 in increments of 20 pence. Participants were told that the computer would bid 184 
against them on each trial but the bid would not be disclosed to them. As per the rules of the 185 
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auction, one trial would be randomly selected at the end of the auction (subjects therefore did 186 
not have to spread their £3 budget across different trials, and were instructed to treat every 187 
trial as if it were the only one). If their bid for the food item on the selected trial was larger than 188 
the computer's, they would win that food item, get a chance to eat it after the scanning session 189 
and only have to pay the amount the computer bid (which would be less than their bid) and 190 
keep any remaining change. If, however, the computer outbid them or matched their bid, they 191 
would not win the food item but would get to keep their £3 budget. Given this set-up, the 192 
auction is incentive-compatible, i.e. the best strategy is to place a bid close to what one is 193 
actually willing to pay. As the actual amount paid is determined by the computer’s bid on the 194 
selected trial, bidding higher amounts risks having to pay more than one’s subjective value. 195 
Bidding lower amounts runs the risk of losing the opportunity to win the item (more cheaply 196 
than one was prepared to pay for it). These rules were all explicitly stated and emphasised to 197 
the subjects as part of the task instructions. Critically, participants were in a hungry state and 198 
were told that they could eat any food they won after the scanning session. 199 
Since each trial entails a number of perceptuomotor components, we used an approach taken by 200 
Plassmann et al., (2007), by including a control task in which the same 50 foods were presented 201 
in “forced” trials (as opposed to the above “free” trials) where subjects were instructed to bid an 202 
amount taken from a random distribution of possible bids from £0 to £3 pounds, again in 20 203 
pence increments. These trials required participants to engage in all the processes involved in 204 
the free trials with the critical difference of requiring no subjective valuation. Moreover, 205 
participants were aware that they would not lose money on such trials.  206 
Fifty trials of each trial type (free and forced), of duration 8 seconds, were presented in a 207 
randomised order. The picture of the food was presented throughout the entire 8-second 208 
duration of a trial. The initial position of the cursor on the sliding scale varied randomly. 209 
Participants placed bids using a standard button box with the first and second buttons serving 210 
to move the cursor down or up the sliding value scale in steps of 20 pence, and the third button 211 
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serving to confirm the final bid and mark the end of the bidding. From this point until the end of 212 
the 8-second bidding trial, the cursor could not be moved further. When the 8-second bidding 213 
trial was over, a feedback screen showing the final bid was presented (Figure 1A). If the bid was 214 
not confirmed within 8 seconds, the feedback screen stated “Not quick enough”. In the analysis, 215 
these trials were considered missed trials. 216 
In fact, for practical reasons, the task was set up to ensure that subjects did not win a food item, 217 
but instead ended up keeping their £3 budget. 218 
Behavioural analysis 219 
Behavioural data were analysed using mixed-effects models (nlme package in R (Pinheiro et al., 220 
2013)), with subjects as a random effect. Post-hoc comparisons, where needed, were done using  221 
the multcomp package (Hothorn et al., 2008). 222 
fMRI data acquisition and analysis 223 
All data were acquired on a Siemens Verio scanner operating at 3 Tesla with a 192mm field of 224 
view at the Wolfson Brain Imaging Centre, Cambridge, UK. A total of 570 gradient echo T2*-225 
weighted echo planar images (EPI) depicting blood oxygenation level dependent (BOLD) 226 
contrast were acquired for each participant. The first six images were discarded to avoid T1 227 
equilibration effects. Images comprised 31 slices, each 3mm thick with a 0.8mm inter-slice gap 228 
and a 64 × 64 data matrix. Slices were acquired in an ascending interleaved fashion, repetition 229 
time = 2000ms, echo time = 30ms, flip angle = 78°, axial orientation = oblique. Data were 230 
analysed using statistical parametric mapping in the SPM8 program (www.fil.ion.ucl.ac.uk). 231 
Images were realigned then spatially normalised to a standard template and spatially smoothed 232 
with an isotropic 3 dimensional Gaussian filter (8 mm full width at half maximum). The time 233 
series in each session were high-pass filtered (with cut-off frequency 1/120 Hz) and serial 234 
autocorrelations were estimated using an AR(1) model.  235 
 236 
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Model 1: Brain responses to value across the entire bidding period and its modulation by 237 
dopamine 238 
Each bidding trial was modelled as a boxcar function, from the onset of the food stimulus until 239 
the bid was confirmed (duration equal to RT, Figure 1B). Separate regressors were created for 240 
free and forced trials. Free and forced bids were used as parametric modulators of these 241 
regressors. Missed trials (in which no bids were selected within 8 seconds) were modelled as a 242 
separate regressor. All regressors were convolved with a canonical haemodynamic response 243 
function with a temporal derivative. Six motion realignment parameters were included as 244 
regressors of no interest.  245 
To examine processes specifically associated with valuation, we calculated the first-level 246 
contrasts as the difference between the parametric modulator of free bid in free trials and 247 
forced bid in forced trials. Given that in forced trials subjects implemented instructed bids, these 248 
trials should not engage the circuitry of interest to us but they should engage all other non-249 
specific processes related to valuation. The applied contrast thus corrects for non-specific 250 
effects and enables identification of regions specifically involved in the valuation-based decision 251 
process. Single-subject contrast images were then entered into a second-level group analysis, 252 
with subjects as a random effect. 253 
At the second level, two analyses were performed: 254 
1. To explore which brain regions are involved in valuation across all subjects, independent of 255 
pharmacological treatment, we computed a one-sample t-test on the single-subject contrast 256 
coefficients from all 43 participants. The analysis was conducted within a pre-defined 10mm 257 
radius sphere in the vmPFC (from the work of Chib et al. (2009)), with a family-wise error 258 
(FWE) small-volume corrected threshold of p<0.05. This was based on our a priori hypothesis 259 
given the strong evidence implicating this region in value computation. In addition, we explored 260 
the existence of value related signals across the whole brain, adopting a threshold of p<0.05, 261 
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FWE corrected at the cluster-level. Additionally, for completeness, we explored the existence of 262 
brain regions whose neural activity separately correlated with free bids in free trials and forced 263 
bids in forced trials. We also explored whether there was a region whose activity tracked the 264 
mismatch between free bid and the randomly ascribed forced bid for the same food item during 265 
forced trials; this entailed examining the existence of correlation between neural activity during 266 
forced trials and a parametric modulator of the difference between the free bid and the randomly 267 
ascribed forced bid for same food item. These additional analyses were conducted at the whole-268 
brain level, using a more liberal threshold of p<0.001, uncorrected.  269 
2.  To explore the effect of the dopaminergic modulation on the neural representation of value, 270 
we performed a non-directional F-test (ANOVA). This was again conducted within the vmPFC 271 
ROI, applying a small-volume corrected threshold of p<0.05, and at the whole-brain level, at a 272 
more liberal threshold of p<0.001 uncorrected, k>20 voxels. This threshold at the whole-brain 273 
level was adopted because it is not possible to apply a cluster-level correction for F-tests in 274 
SPM8 and a voxel-level correction would be too stringent. In case of significant effects, they 275 
were further delineated using two-sample t-tests at the whole-brain cluster-level and within the 276 
vmPFC sphere, at a FWE corrected threshold of p<0.05. 277 
 278 
Model 2: Does dopamine have different contributions to different phases of the 279 
bidding/valuation process? 280 
This post-hoc analysis aimed to establish the temporal specificity of the dopaminergic effects 281 
and, in so doing, to relate them to the early (initial valuation) and late (value-dependent action) 282 
stages of the bidding process. A modified first-level model was estimated that looked for 283 
changes in the correlation of BOLD activity with the bid separately for early and late phases of 284 
each trial. 285 
 286 
To model the early and late stages of the bidding process, two regressors were created for each 287 
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subject. These two regressors were modelled as 0s stick functions: an early period regressor 288 
was set at the time of food photo (and trial) onset, and a late period regressor was set at a time 289 
half-way from the food photo onset to the bid confirmation (RT/2). This was done separately 290 
for each trial (Figure 1C). Whereas at the first time point no responding took place, at the 291 
second time point, participants were responding to select the bid. Missed early and late 292 
regressors were modelled as separate 0s stick functions, with the late time point regressor 293 
modelled at 4s (halfway through the trial). The parametric modulators of bids for early and late 294 
time points were the same for a given trial. To identify neural representations of value at each 295 
time point, two separate single-subject contrasts were computed: the early neural 296 
representation of value as the difference between the parametric modulator of free bid and 297 
forced bid at the early time point; and the late neural representation as the difference between 298 
the parametric modulator of free bid and forced bid at the late time point. 299 
 300 
The two contrast images per each individual were put forward to the second-level group 301 
analysis, with subjects as a random effect. At the group level we used a 2x3 factorial ANOVA to 302 
explore the interaction between time and drug on the neural representation of value. This 303 
analysis was confined to a 10mm-radius sphere around the peak voxel exhibiting the strongest 304 
dopaminergic modulation of neural representation of value, established in the previous 305 
analysis. The analysis was conducted at a FWE small-volume corrected threshold of p<0.05. 306 
  307 
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Results 308 
Behavioural results 309 
Missed trials 310 
Predictably, there were significantly fewer missed trials within the free than in the forced trials 311 
(free (mean±SEM): 0.48± 0.12, forced (mean±SEM): 1.52± 0.27, F=17.49, p=0.0001), however 312 
this did not differ across groups (trial type-by-group interaction F=0.14, p=0.87). 313 
Bid 314 
Despite a clear trend for higher free bids in the sulpiride group (Figure 2A), the effect of 315 
treatment did not reach significance (F=2.83, p=0.07). Pairwise comparisons revealed a 316 
strongest difference between sulpiride and bromocriptine, however this did not reach 317 
significance (sulpiride versus bromocriptine, z=2.16; p=0.08, placebo versus bromocriptine 318 
z=0.23, p=0.97; sulpiride versus placebo z=1.96, p=0.12, Tukey-corrected for multiple 319 
comparisons).  320 
Free bids were found to be positively correlated with the initial random position of cursor on 321 
the bidding scale (t=6.09, p<0.0001), however, this did not differ between different treatment 322 
groups (initial cursor position-by-treatment group interaction F=1.76, p=0.17). Adding the 323 
initial cursor position as the covariate into the model exploring the effect of treatment group on 324 
the bid did not change the reported results. 325 
Reaction time 326 
Individual reaction times (RTs) were, of course, dependent on the initial position of the cursor 327 
since this would determine how far they were required to move in order to finalise the 328 
selection. There was thus a correlation between starting point and RT (t=10.15, p<0.0001). To 329 
account for this, the number of button presses made to select the bid was entered as a covariate 330 
into the model exploring the effect of trial type and drug treatment on RT. The analysis revealed 331 
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a significant effect of trial type (F=398.39, p<0.0001), with subjects, as expected, being quicker 332 
on forced compared to free trials (Figure 2B). There was no main effect of treatment (F=1.01, 333 
p=0.37), however there was a significant treatment-by-trial type interaction (F=3.7, p=0.025). 334 
None of the pairwise comparisons between drug treatments in the free condition reached 335 
significance, however, as evident from the plot, there was a trend of shorter RTs under sulpiride 336 
in comparison to placebo and bromocriptine (placebo versus bromocriptine z=0.47, p=0.86;  337 
sulpiride versus bromocriptine z=-1.29, p=0.39; sulpiride versus placebo z=-1.78, p=0.18;  338 
Tukey corrected for multiple comparisons). As evident from the plot, the analogous analysis 339 
within the forced trials revealed no difference in reaction RTs between drug treatments 340 
(placebo versus bromocriptine z=-0.46, p=0.89; sulpiride versus bromocriptine z=-0.85, p=0.67; 341 
sulpiride versus placebo z=-0.41, p=0.91; Tukey corrected for multiple comparisons). 342 
fMRI results 343 
As described above, two key analyses were performed. Our first analysis treated the entire 344 
duration of the bidding (equal to RT, mean RT±SD = 4.1±1.37s) as the period of interest to 345 
identify regions sensitive to value and dopaminergic modulation (Model 1, Figure 1B). Next we 346 
sought to determine whether in these regions, there were differential effects of dopamine on 347 
different aspects of the bidding process (Model 2, Figure 1C). Model 2 examined whether the 348 
drug effects were specific to a particular stage of each trial. Dividing every trial into early and 349 
late phases (corresponding approximately to initial valuation and value-dependent action) on 350 
the basis of the response made, we explored the interaction between drug, value (bid size) and 351 
trial phase (early versus late).  352 
 353 
 354 
 355 
 356 
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The neural representation of value (Model 1) 357 
Examination of the brain regions involved in valuation across all study participants revealed 358 
activity correlating with subjective value within the pre-defined region of vmPFC (pFWE<0.05, 359 
small volume corrected, Figure 3A), consistent with theory and previous work (Bartra et al., 360 
2013; Clithero and Rangel, 2013). Further, several clusters were seen (whole-brain cluster-level 361 
pFWE<0.05) including a large cluster encompassing the left and right posterior parietal cortex 362 
(maxima located in the region of intraparietal sulcus (IPS) on both sides) and extending to the 363 
left fusiform gyrus and further clusters in middle and inferior frontal gyri bilaterally and in the 364 
right fusiform/lingual gyrus (Figure 3B and Table 1). 365 
For completeness, we conducted two additional analyses. Firstly, we explored the correlation of 366 
neural activity with free and forced bids separately. Whereas the neural activity correlating with 367 
free bids in free trials mimicked the pattern of neural activity in our main contrast, there was no 368 
region, even at a liberal threshold of p<0.001 uncorrected, whose activity correlated with forced 369 
bids in forced trials. This confirms that the effects established in our main contrast were not 370 
driven by activity associated with forced trials. Secondly, we also investigated whether there 371 
was a region whose activity tracked the mismatch between free bid and the randomly ascribed 372 
forced bid for the same food item during forced trials. That is, we determined whether being 373 
forced to make a bid that markedly deviated from how one would normally value a given item 374 
was associated with enhanced responses. However, no such region was detected, even at a 375 
liberal threshold of p<0.001 uncorrected. 376 
Dopaminergic drugs modulate the neural response to value in the left and right inferior 377 
parietal gyrus/intraparietal sulcus  (Model 1) 378 
We next explored the effect of the administered dopaminergic drugs on the valuation-379 
dependent brain activity. The ANOVA comprising the three levels of pharmacological treatment 380 
found no effect of treatment in the vmPFC (this was also true for a more liberal threshold, 381 
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p<0.001 uncorrected). A significant effect of dopaminergic treatment was found in the right 382 
middle frontal gyrus and in the left and right inferior parietal gyrus, in close vicinity of the IPS 383 
(IPG/IPS; p<0.001 uncorrected, k>20 voxels; Table 2, Figure 4A). 384 
To establish more precisely what drove this effect, additional two-sample t-tests were 385 
performed. Compared to sulpiride, bromocriptine was associated with a stronger relationship 386 
between value and activity in the IPG/IPS bilaterally (corrected for multiple comparisons at the 387 
cluster-level, pFWE<0.05, Table 3, Figures 4B and 4D); in other words, it increased the strength of 388 
correlation between the bids and the BOLD response. Further t-tests between individual 389 
pharmacological treatments did not reveal any significant clusters at the same threshold.  390 
Interestingly, these two clusters were close to the posterior parietal cluster identified in the 391 
previous contrast. As can be seen from the parameter estimates (Figure 4C), there was a trend 392 
towards reduced neural representation of value within the sulpiride group in the posterior 393 
parietal cluster, however, the clear distinction between the groups was only seen in the L- and 394 
R-IPG/IPS clusters. 395 
In summary, we found that the neural response to value is significantly affected by 396 
pharmacological manipulation of dopaminergic function in the IPG/IPS region and this effect 397 
was driven by the bromocriptine versus sulpiride contrast. 398 
Dopaminergic treatment modulates the neural representation of value in the left inferior 399 
parietal gyrus/intraparietal sulcus during the late stage of valuation (Model 2) 400 
Here, we investigated whether the dopaminergic modulation is specific to the early or late stage 401 
of the valuation process. We focused specifically on the regions showing an effect of drug across 402 
the whole trial, splitting this trial into early and late phases (with the split-point determined 403 
based on time-to-decision for each trial separately). A significant time-by-drug interaction was 404 
established in a 10mm-radius sphere around the peak voxel in the left IPG/IPS demonstrating 405 
the strongest effect of dopaminergic treatment in the previous model (pFWE<0.05, small volume 406 
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corrected, Table 4, Figure 5A). As evident from the parameter estimates extracted from each of 407 
six conditions (Figure 5B), the effect of dopaminergic manipulation on valuation was greater 408 
during the later (value-dependent action) phase compared to the earlier (initial valuation) 409 
phase. This result suggests that the modulation of strength of correlation between the bids and 410 
the BOLD signal in the left IPG/IPS, increasing with bromocriptine and decreasing with 411 
sulpiride, becomes more pronounced closer to the point when an appropriate action is used to 412 
record the final bid, i.e. when the participant makes a fine-grained decision about whether the 413 
bid should be 20p more or less, which in the context of our task might indicate a dopaminergic 414 
influence on the fine tuning of the valuation process. 415 
  416 
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Discussion 417 
In this pharmacological fMRI study we used the established BDM mechanism with food rewards, 418 
in a sample of hungry participants, to assess the role of dopamine in subjective valuation. We 419 
characterised the effects of dopaminergic modulation, using both an agonist and an antagonist, 420 
demonstrating its role in the coding of value in the IPS.  Compared to sulpiride, bromocriptine 421 
enhanced the neural representation of value in the IPS. Moreover, a significant drug-by-value-422 
by-trial phase interaction indicated that the dopaminergic modulation of neural response was 423 
specific to the late phase of the trials, when an action was needed to record the value. 424 
 425 
While there is a rich literature on the role of dopamine in value learning (Bayer and Glimcher, 426 
2005; Schultz, 1998; Schultz et al., 1997; Steinberg et al., 2013; Wise, 2004), there is relatively 427 
little exploring its role in value computation during decision-making. Recent studies in healthy 428 
adults and patients with Parkinson’s disease have partly addressed this using a probabilistic 429 
learning/choice task, demonstrating that dopamine biases choice towards more valuable 430 
options (Jocham et al., 2011; Shiner et al., 2012; Smittenaar et al., 2012) and enhances the 431 
expression of value in the vmPFC (Jocham et al., 2011). However, the learning nature of these 432 
tasks prevents a clear dissociation of dopaminergic effects on learning and performance/choice 433 
(particularly given that in Jocham et al. (2011) the dopamine-modulated prediction error 434 
expressed during the learning phase also predicted choice in the performance phase). Our 435 
results concur with these findings, and complement them by demonstrating a dopaminergic 436 
component of value computation in response to already well-learned items. Furthermore, the 437 
realistic nature of the task and the inclusion of highly-familiar foods as auction items more 438 
closely mimics every day value computations we make, which, compared to choosing between 439 
probabilistic stimulus-reward associations, are more complex and are thought to entail 440 
integration of various attributes into a single measure of subjective value, which can be then 441 
used as input for making choices (Rangel et al., 2008). 442 
 443 
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Interestingly, while our first analysis (“Model 1”) replicated previous work in showing value 444 
signals in several brain regions including vmPFC (Bartra et al., 2013; Clithero and Rangel, 2013; 445 
Hunt et al., 2012; O’Doherty, 2011), only in the IPS was value representation modulated by 446 
dopamine. The finding of a dopaminergic effect in the IPS and not in the vmPFC, and the 447 
relatively late timing of this signal, suggests that a different, dopamine-sensitive value 448 
computation is being processed in the IPS.  We are cautious about interpreting a null effect in 449 
vmPFC but it is worth noting that the association of BOLD activity in this region with value has 450 
been generally established at the initial stages of the decision-making process and is thought to 451 
serve as an input to later stages of decision-making (Rangel, 2010; Rangel and Clithero, 2013). 452 
Conversely, posterior parietal cortex has been implicated as central to action-based decision-453 
making (Dorris and Glimcher, 2004; Musallam et al., 2004; Platt and Glimcher, 1999; Sugrue et 454 
al., 2004). Notably, one part of this region, the lateral intraparietal area has been found to 455 
represent a spatial map for guiding saccades (Snyder et al., 1997), and to encode the value of 456 
rewards associated with individual saccades (Dorris and Glimcher, 2004; Platt and Glimcher, 457 
1999; Sugrue et al., 2004). The parietal reach region analogously represents the movement of 458 
forelimbs (Baumann et al., 2009; Connolly et al., 2003; Scherberger and Andersen, 2007), and 459 
the firing of these neurons correlates with the expected value of the movement's outcome 460 
(Musallam et al., 2004). These findings suggest that these two areas encode the value of 461 
movements. Human studies have also related measures of action value to activity in the 462 
IPS/posterior parietal cortex (Chowdhury et al., 2013; Gershman et al., 2009; Hunt et al., 2012; 463 
Iyer et al., 2010; Wunderlich et al., 2009).  464 
One possibility is that dopaminergic enhancement of the neural representation of value reflects 465 
an increase in the signal to noise ratio (SNR) of the value representation. Evidence for this 466 
comes from studies of the decline in dopamine function with aging (reviewed in Bäckman et al., 467 
(2006)). Neural network simulations modelling age-related decline in dopaminergic function as 468 
attenuated gain control of SNR (Eppinger et al., 2011; Li et al., 2001) have suggested a plausible 469 
mechanistic link between reduced dopaminergic function, attenuated neural representation of 470 
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the value of stimuli and impairments in decision-making. Furthermore, studies in older adults 471 
demonstrated that the increased BOLD signal temporal variability (Samanez-Larkin et al., 472 
2010a) and reduced neural representation of expected value (Samanez-Larkin et al., 2010b) 473 
were predictive of poorer decision-making. Our results complement these findings by directly 474 
showing the effects of dopaminergic modulation on the neural representation of value. 475 
Moreover, the fact that the drug modulations occurred late in the trials (i.e. close to the final 476 
selection of the bid) suggests that dopamine modulates the dynamic process of fine tuning the 477 
neural representation of value as the basis for completing the decision/action. 478 
Behaviourally, we did not detect an effect of dopaminergic treatment on the magnitude of bids, 479 
perhaps as consequence of the relatively mild pharmacological perturbation induced. However, 480 
the presence of significant neural alterations in the context of matched behaviour offers some 481 
advantages to interpreting the former more clearly, in keeping with previous theoretical 482 
perspectives (Wilkinson and Halligan, 2004). Moreover, to the best of our knowledge, there is 483 
no data demonstrating that dopamine increases value in a context dissociated from learning, A 484 
more detailed analysis of the RTs revealed that the average time to decide on the size of the bid 485 
was reduced in the sulpiride condition, suggestive of decreased deliberation on the value of 486 
individual foods. Interestingly, this effect was paralleled by a trend towards larger bids in the 487 
sulpiride condition. In fact, the average bid under sulpiride is much closer to the mean bid in the 488 
forced condition (see Figure 2A). Given that the bids in the forced condition were taken from a 489 
random, uniform distribution, we speculate that sulpiride, and the proposed decrease in SNR of 490 
value representation, were associated with more random, less deliberative bids. 491 
 492 
Finally, it is noteworthy that part of the posterior parietal region lying in close proximity to the 493 
dopamine-dependent value coding region identified in this study has been found to be related to 494 
goal-directed behaviour (Glascher et al., 2010). Given that dopamine has been implicated in 495 
mediating the balance between the habitual and goal-directed systems, with increased 496 
dopaminergic activity shifting the behaviour towards a more dominant goal-directed control 497 
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(de Wit et al., 2011, 2012; Wunderlich et al., 2012), and given the importance of valuation in 498 
goal-directed behaviour, we speculate that our agonist and antagonist drugs shifted this balance 499 
in different directions with the former promoting more measured, goal-directed responding and 500 
the latter, through reducing value SNR, prompting more rapid responses divorced from goal 501 
values. Of course, this is a speculation and our experimental design does not allow us to test it 502 
directly.  503 
Certain limitations must be acknowledged. The between-subject design prevented analyses of 504 
potential brain-behaviour correlations. Further, while pharmacological fMRI is widely used and 505 
provides a targeted, non-invasive way of investigating neural processes, there are some basic 506 
limitations of the approach. Given the limited data on dose and receptor occupancy 507 
relationships for these agents, doses and administration protocols are based on the known 508 
pharmacokinetics of these drugs and on previous studies that have successfully used them to 509 
perturb dopaminergic function (Cools et al., 2009; Dodds et al., 2009; Mehta et al., 2008; 510 
Morcom et al., 2010). Dosages are also limited by what can be deemed clinically tolerable for 511 
healthy volunteers.  Furthermore, there are studies reporting effects different from our findings 512 
– namely, enhanced neural value representation and improvement in performance associated 513 
with D2 antagonists, presumably linked to pre-synaptic auto-receptors effects (Jocham et al., 514 
2011; Frank and O’Reilly, 2006). The preponderance of post- versus pre-synaptic effects is 515 
believed to vary depending on the exact drug used, its concentration, the basal level of 516 
dopamine in the system (discussed in Frank and O’Reilly (2006)), as well as on the brain area of 517 
the studied effect, given the different distribution of post- and pre-synaptic receptors 518 
throughout the brain (Kilts et al., 1987).  It is not possible to entirely exclude the possibility of 519 
auto-receptors effects in our study though the directionally of our effects does instil some 520 
confidence that we are seeing predominantly post-synaptic effects. 521 
In summary, we explored the role of dopamine in the neural representation of value without the 522 
confound of learning. We investigated the direct role of dopamine in the expression of value that 523 
Dopamine modulates the neural representation of subjective value of food in hungry 
subjects  
 23 
has been already learned through life experience, and whose accurate expression is a requisite 524 
of goal-directed behaviour. Our results suggest that dopamine enhances the neural 525 
representation of value in the IPS. The effect predominates towards the end of the valuation 526 
process, at the point where the decision becomes explicit in action. These findings provide a 527 
dopamine-dependent mechanism underlying impaired decision-making in healthy individuals 528 
and clinical populations with reduced dopamine levels.  529 
  530 
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Figure legends 670 
Figure 1. Task structure and model specification.  671 
A. The auction task featured 50 snack items presented as part of free and forced trials. Free and 672 
forced trials, of duration 8s, were presented in a randomised order. After the bidding trial was 673 
over, a 1s feedback screen showing the final bid was presented. This was followed by a 0.5s 674 
blank screen.  On 30 random occasions during the course of the task, a 6s null trial with a 675 
fixation cross was presented after the blank screen. 676 
B. fMRI model 1 schematic. Each bidding trial was modelled as a boxcar function (depicted as a 677 
pink rectangle), from the onset of the food stimulus until the bid was confirmed (duration equal 678 
to RT). 679 
C. fMRI model 2 schematic. Two time points within each bidding trial were modelled as events 680 
within the trial (0s stick or delta functions, depicted as pink rectangles): an early phase 681 
regressor set at the time of food stimulus onset, and a late phase regressor set at a time half-way 682 
from the food photo onset to the bid confirmation (RT/2), separately for each trial. 683 
Figure 2. Behavioural results.  684 
A. Average bid by treatment group in the free trial condition. Error bars represent SEM of each 685 
subject's average bid. Presented on the same graph is the mean of the uniform distribution of 686 
instructed forced bids. 687 
B. Average RT by treatment group and trial type. Error bars represent SEM of each subject’s 688 
average RT. 689 
 690 
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Figure 3. Neural representation of value.  692 
Significant areas of activation were rendered onto a standard SPM8 T1 template image, with 693 
corronal and sagittal sections presented at the coordinates appropriate for displaying relevant 694 
regions.  695 
A. The neural representation of value was found within the pre-defined 10mm-radius sphere in 696 
the vmPFC region (pFWE<0.05, small-volume corrected).  697 
B. Equally, value-coding clusters were found in regions surviving the whole-brain correction at 698 
the cluster-level (pFWE<0.05). These include a large cluster encompassing the left and right 699 
posterior parietal cortex (maxima located in the region of IPS on both sides) and extending to 700 
the left fusiform gyrus and further clusters in middle and inferior frontal gyri bilaterally and in 701 
the right fusiform / lingual gyrus. 702 
Full details of the activation foci are given in Table 1. 703 
Figure 4. Dopaminergic modulation of the neural representation of value.   704 
Significant areas of activation were rendered onto the standard SPM8 T1 template image, with 705 
corronal and sagittal sections presented at the coordinates appropriate for displaying relevant 706 
regions. 707 
A. Activation areas in the left and right IPG/IPS and in the right middle frontal gyrus that 708 
exhibited an effect of drug on the neural representation of value (p<0.001 uncorrected, k>20 709 
voxels).  710 
B. Displayed in green are the activation areas in the left and right IPG/IPS in which there was an 711 
enhancement of the neural representation of value in the bromocriptine compared to the 712 
sulpiride treatment group (pFWE<0.05, whole-brain corrected at the cluster-level). Value-coding 713 
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clusters, common to all three treatment groups, are presented in magenta ((pFWE<0.05, whole-714 
brain corrected at the cluster-level). 715 
C. Presented inside the magenta box are the parameter estimates of the neural representation of 716 
value averaged per treatment groups, extracted from the large value-coding cluster spanning 717 
the left and right posterior parietal cortex (presented in magenta on the images in panel B). 718 
D. Presented inside the green box are the parameter estimates of the neural representation of 719 
value averaged per treatment groups, extracted from the left and right IPG/IPS clusters of the 720 
bromocriptine versus sulpiride contrast (presented in green on the images in panel B). 721 
Error bars represent SEM. Full details of the activation foci are given in Tables 2 and 3. 722 
Figure 5. Dopaminergic treatment modulates the neural representation of value in the 723 
left inferior parietal gyrus/intraparietal sulcus during the late stage of valuation. 724 
Corronal (at y=-54mm to the anterior commissure) and sagittal sections (at x=-54mm to the left 725 
of the mid-line) from the standard SPM8 T1 template image.  726 
A. The analysis was confined to a 10mm-radius sphere around the voxel in the left IPG/IPS that 727 
showed the strongest dopamine-dependent modulation in model 1, and is depicted here in 728 
green. Presented in yellow are the voxels within this sphere showing a significant treatment 729 
(placebo, bromocriptine, sulpiride) by time (early, late) interaction. For display purposes, both 730 
contrasts are presented at p<0.01 uncorrected. 731 
B. Presented inside the yellow box are the parameter estimates of the neural representation of 732 
value for each of the six conditions: treatment (placebo/bromocriptine/sulpiride) and time 733 
(early/late).  The parameter estimates were extracted from the voxels exhibiting the treatment-734 
by-time interaction within the described sphere (presented in yellow on the image in panel A). 735 
Error bars represent SEM. Full details of the activation foci are given in Table 4. 736 
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Table legends 737 
Table 1. Regions correlated with subjective value. 738 
Table 2. Regions exhibiting a dopaminergic modulation of the neural representation of value.  739 
Table 3. Regions with an enhanced neural representation of value under bromocriptine, 740 
compared to sulpiride.  741 
Table 4. Activation peak exhibiting a time-by-treatment interaction in the left IPG/IPS.742 
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Figure 2 
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Figure 3 
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Figure 4 
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Figure 5 
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Tables 
 Table 1 Regions correlated with subjective value.  
 Side Cluster 
Size 
Peak MN coordinates Peak scores 
Region   x y Z T Z 
Intraparietal Sulcus L/R 7354 -26 -66 46 6.4 5.32 
Middle Frontal Gyrus  L 425 -24 2 58 5.75 4.91 
Middle Frontal Gyrus  R 744 25 -1 54 5.5 4.74 
Fusiform Gyrus/Lingual Gyrus R 833 28 -64 -8 5.24 4.57 
Inferior Frontal Gyrus R 604 50 6 26 4.86 4.3 
Middle Frontal Gyrus R 286 46 42 10 4.25 3.86 
Inferior Frontal Gyrus L 248 -48 2 34 4.1 3.74 
Anterior Cingulate/Medial Frontal Gyrus*  L/R 81 0 44 2 3.71 3.43 
p<0.05 whole-brain FWE correction for multiple comparisons at the cluster-level (p<0.001 uncorrected threshold). 
*Survives p<0.05 small-volume FWE correction within a 10mm sphere around the vmPFC coordinates (-3, 42, -6) 
from the work of Chib et al. (2009). 
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Table 2 Regions exhibiting a dopaminergic modulation of the neural representation of value.  
 Side Cluster 
Size 
Peak MNI coordinates Peak scores 
Region   x Y Z F Z 
Middle Frontal Gyrus R 55 32 0 58 12.62 3.86 
Inferior Parietal Gyrus/Intraparietal 
Sulcus 
L 63 -50 -50 46 11.17 3.63 
Inferior Parietal Gyrus/Intraparietal 
Sulcus 
R 40 52 -50 48 9.95 3.42 
p<0.001 uncorrected, extent k>20 voxels. 
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Table 3 Regions with an enhanced neural representation of value under bromocriptine, compared to 
sulpiride.  
 Side Cluster 
Size 
Peak MNI coordinates Peak scores 
Region   x y Z T Z 
Inferior Parietal Gyrus/Intraparietal 
Sulcus 
L 494 -50 -50 46 4.66 4.14 
Inferior Parietal Gyrus/Intraparietal 
Sulcus 
R 363 52 -50 48 4.45 3.99 
p<0.05 whole-brain FWE correction for multiple comparisons at the cluster-level (p<0.001 uncorrected threshold).   
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Table 4 Activation peak exhibiting a time-by-treatment interaction in the left IPG/IPS.  
 Side Cluster Size Peak MNI coordinates Peak scores 
Region   X Y Z F Z 
Inferior Parietal 
Gyrus/Intraparietal Sulcus 
L 10 -54 -54 50 8.79 3.39 
p<0.05 small-volume FWE correction within a 10mm sphere around the peak voxel in the left IPG/IPS (-50,-50, 46) 
which showed an effect of drug across the entire bidding trial (model 1). 
 
 
